Article
Genotype-Associated Differential NKG2D Expression on CD56+CD3+ Lymphocytes Predicts Response to Pegylated-Interferon/Ribavirin Therapy in Chronic Hepatitis C.
PloS one - 1 Jan 2015
Chu Po-sung, Ebinuma Hirotoshi, Nakamoto Nobuhiro, Sugiyama Kazuo, Usui Shingo, Wakayama Yuko, Taniki Nobuhito, Yamaguchi Akihiro, Shiba Shunsuke, Yamagishi Yoshiyuki, Wakita Takaji, Hibi Toshifumi, Saito Hidetsugu, Kanai Takanori
Abstract excerpt
Hepatitis C virus (HCV) genotype 1 infections are significantly more difficult to eradicate with PEG-IFN/ribavirin therapy, compared to HCV genotype 2. The aim of this work is to investigate the difference of immunological impairments underlying this phenomenon. Pre-treatment NKG2D expression on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
